Simple Summary Non-Alcoholic Fatty Liver Disease (NAFLD) is a prevalent extraintestinal
manifestation in patients with Inflammatory Bowel Disease (IBD). Liver fibrosis is the …

Inflammatory bowel diseases (IBD), comprising Crohn's disease and ulcerative colitis, are
systemic and multifaceted disorders which affect other organs in addition to the …

Inflammatory bowel disease (IBD) is an immune-mediated gut dysfunction, which might also
be associated with an inflammatory phenotype in the liver. It is known that the nutritional …

Background Inflammatory bowel disease (IBD) patients have a higher risk of metabolic
dysfunction-associated fatty liver disease (MAFLD) compared with the general population …

Abstract Background and Aims Crohn's disease (CD) confers an increased risk of
nonalcoholic fatty liver disease (NAFLD), but the pathogenesis remains poorly understood …

Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases that have
been associated with nonalcoholic fatty liver disease (NAFLD). This systematic review …

Abstract Background and Aim Up to a third of patients with inflammatory bowel disease (IBD)
have elevated liver enzymes (ELE). We evaluated the incidence, predictors, and outcomes …

Background and Aims Prior studies suggest an increased risk of non-alcoholic fatty liver
disease (NAFLD) in patients with inflammatory bowel disease (IBD). We aimed to investigate …

Having a standard approach to the most common liver disease presentations and care
pathway for NAFLD will improve the quality of care provided and ease the medical decision …